# Filing Detail

Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001641172-25-013068
Filing Date
2025-05-30
Accepted
2025-05-30 16:45:35
Documents
17
Period of Report
2025-05-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | formpre14a.htm iXBRL | PRE 14A | 1130010
2 | GRAPHIC | proxy_001.jpg | GRAPHIC | 346110
3 | GRAPHIC | proxy_002.jpg | GRAPHIC | 164988
| Complete submission text file | 0001641172-25-013068.txt |  | 3068938

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
4 | XBRL SCHEMA FILE | imnn-20241231.xsd | EX-101.SCH | 4578
5 | XBRL DEFINITION FILE | imnn-20241231_def.xml | EX-101.DEF | 8910
6 | XBRL LABEL FILE | imnn-20241231_lab.xml | EX-101.LAB | 59552
7 | XBRL PRESENTATION FILE | imnn-20241231_pre.xml | EX-101.PRE | 44606
19 | EXTRACTED XBRL INSTANCE DOCUMENT | formpre14a_htm.xml | XML | 147076

Mailing Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648
Business Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648 (609) 896-9100
Imunon, Inc. (Filer) CIK: 0000749647 (see all company filings)

EIN.: 521256615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-15911 | Film No.: 251011735
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)